DOCS Stock Up in Pre-Market Post Q1 Earnings Beat, Gross Margin Down

Doximity, Inc. (DOCS) reported strong first-quarter fiscal 2026 results, with adjusted EPS of 36 cents (+28.6% YoY) and revenues of $145.9 million (+15.2% YoY), both surpassing consensus estimates and driving a nearly 7.7% pre-market stock gain. The company also raised its full fiscal year 2026 revenue guidance to $628 million-$636 million, exceeding prior outlook and analyst expectations, attributed to robust subscription revenue growth and increased user engagement, despite a slight 13 basis point contraction in gross margin.

Analysis

Doximity, Inc. (DOCS) reported a robust first quarter for fiscal 2026, significantly outperforming market expectations. Adjusted EPS of 36 cents marked a 28.6% year-over-year increase, beating the Zacks Consensus Estimate by 16.1%. Similarly, revenues grew 15.2% to $145.9 million, surpassing consensus by 4.5% and triggering a 7.7% pre-market stock gain. This top-line growth was driven by a 14.9% increase in the core Subscription segment, supported by both new customer acquisition and a notable 14% rise in average revenue from existing marketing clients. Operationally, the company demonstrated leverage by expanding its operating margin by 101 basis points to 37.4%, as operating profit growth of 18.4% outpaced total operating expense growth of 12.7%. However, this was contrasted by a slight gross margin contraction of 13 basis points and significant increases in research and development (+18.7%) and general and administrative (+34.4%) expenses. Management's confidence is underscored by a raised full-year revenue forecast to $628-$636 million and a Q2 revenue projection of $157-$158 million, both of which are above consensus estimates. This positive outlook is further supported by double-digit growth in active users and the recent launch of the Doximity AI scribe, signaling potential new growth avenues.

Key Decisions for Investors

• Given the strong top and bottom-line beats and upwardly revised guidance that surpasses consensus, investors may view the current momentum as a positive signal for near-term performance.
• It is crucial to monitor the company's margin profile, particularly the 13 bps gross margin contraction, in the context of rising R&D and G&A investments to ensure they translate into sustainable future growth.
• The success and market adoption of new strategic initiatives, such as the Doximity AI scribe, should be tracked closely as key catalysts for long-term value creation and justification of the company's growth valuation.
• Despite strong operating cash flow growth to $62.1 million, the significant decrease in cash and cash equivalents from the end of fiscal 2025 warrants attention to understand the company's capital allocation strategy.